Sandra Nora González Díaz, MD, PhD
Sandra Nora González Díaz is Head and Professor of Allergy and Clinical Immunology, Department of Internal Medicine, University Hospital and General Director of Development and Graduates of Autonoma University of Nuevo Leon (UANL).
She studied medicine in UANL, Monterrey, Mexico (1977-1983), did Social Service in Allergy and Clinical Immunology Department, University Hospital, Monterrey (1983-1984). She completed training in Internal Medicine at University Hospital, Monterrey (1986-1988), and coursed a fellowship in Allergy and Pediatric Clinical Immunology at University of San Diego, California, UCSD (1987-1988) and finished her training in Allergy and Clinical Immunology Specialization at University Hospital, Monterrey (1988-1990); where she concluded her doctorate (1991-1997).
Prof. González serves on numerous international committees of several academic organizations, grant reviews and editorial boards. She is a Member/Fellow of many Academic Organizations; including AAAAI, ACAAI, EAACI, and WAO for which is currently participates as a member of Board Directors, Audit and Finance Committee, Bylaws Committee, Communications Council, Congress Council, GLORIA Advisory Board, Emerging Societies Program Council and Centers of Excellence. She was President of SLAAI and Mexican College of Allergy and Clinical Immunology. She has delivered numerous lectures nationally and internationally, received several academic awards and recognized worldwide for her excellence practice and achievements in medicine.
Prof. González’s research has focused on asthma education, asthma and pregnancy, cost of asthma and allergy diseases, educational camps and sports; perception of asthma control, hymenoptera allergy epidemiology in Latin America, burden of allergic rhinitis, and use of immunotherapy. She has 362 publications. She is also an Editor/Associate Editor of peer-reviewed journals and books.
Her vision is education to primary care physicians in recognizing the impact of allergic diseases. The importance of working to generate bidirectional lines of dialogue with government to implement innovative prevention measures in asthma and allergy, as well as generation of public health laws that improve patient care.